Skip to main content
. 2015 Aug 25;2015:517472. doi: 10.1155/2015/517472

Figure 1.

Figure 1

(a) Urinary concentrations of Alb normalized by urinary concentrations of creatinine (UAlbCR) before and 12-week after treatment with alogliptin. Alogliptin treatment tended to decrease UAlbCR (99.6 ± 26.8 versus 114.6 ± 36.0 mg/g Cr, P = 0.1976). (b) UAlbCR of each participant before and 12-week after treatment with alogliptin.